Dr Reddy's Lab recalls Famotidine tablets from US market as drug fails impurities specifications

Hyderabad: Dr Reddy's Laboratories has initiated voluntarily recall of over half a million Famotidine tablets bottles from the US market as the drug failed impurities or degradation specifications.

Dr Reddys Lab recalls Famotidine tablets from US market as drug fails impurities specifications

Representational image. Reuters.

According to a notification put up by the US Food and Drug Administration, the recall is being made under 'Class-III' classification, which is described as 'a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences'.

"Failed impurities/degradation specifications: Famotodine has an out of specification result for an individual related substance observed during routine stability testing of a batch for related substances -impurity 8 at 24 month stability interval," the notification said on the reasons for recall.

As many as 5,69,376 bottles of Famotidine tablets, 10 mg belonging to multiple lots packaged in 30-count, are being recalled nationwide.

The drug is an over-the-counter (OTC) product used to treat and prevent ulcers in stomach and intestines.

Firstpost is now on WhatsApp. For the latest analysis, commentary and news updates, sign up for our WhatsApp services. Just go to Firstpost.com/Whatsapp and hit the Subscribe button.

Updated Date: Oct 20, 2017 16:36:18 IST

Also See